** Brokerage Wells Fargo upgrades telemedicine firm American Well Corp to "overweight" from "equal weight"; maintains PT of $15
** Brokerage expects co's Converge platform to have been fully deployed with U.S. Defense Health Agency (DHA) by the end of Q4, implying it will generate revenue of a subscription model throughout 2025
** Co's Converge platform integrates in-person, virtual, and automated healthcare care into one system
** Brokerage says co's contract with DHA will generate $50 mln in revenue in 2025
** Brokerage believes AMWL's sales strategy pivot, led by incoming CFO Mark Hirschhorn, could lead to a more comprehensive "go-to-market strategy"
** Stock fell 75% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.